were prepared and characterized. Patches ex vivo permeation through rat skin was studied, kinetic analysis and permeation mechanism were investigated. Results: Chitosan, oil phase and surfactant to oil ratios
from 91.23%, 84.03% respectively. Release of TH from the prepared films followed zero order kinetics and the mechanism was found to be non-Fickians diffusion and followed anomalous release. Hence
forms were evaluated for weight variation, in-vitro release profile study and drug release kinetic studies as per I.P. /U.S.P. The optimized batch was studied for the stability study
were prepared and characterized. Patches ex vivo permeation through rat skin was studied, kinetic analysis and permeation mechanism were investigated. Results: Chitosan, oil phase and surfactant to oil ratios
liposomes were studied for shape and physical interaction (and integrity), in vitro drug release kinetics modelling, haemolytic toxicity studies, ex vivo pharmacodynamics (OVCAR-3 cell lines), florescence microscopy…
that FITC?insulin labeled NPs showed higher time-dependant cellular uptake. In vitro release kinetics of insulin from these devices in pH 1.2 media for 2 h, followed
partially arise from the loss of transporters responsible for the cellular uptake of gemcitabine. Kinetic studies have shown that gemcitabine intracellular uptake is preferentially mediated by hENT1
vitro drug release exhibited minimum burst release with sustained release for 12 h. The kinetic study showed the optimized formulation followed Higuchi square root kinetic model with non-Fickian diffusion
selected on the basis of percentage drug entrapment, mean particle size, mucoadhesive strength and kinetic drug release. The drug entrapment efficiency of batch F9 was very high 98.57% and assay ... sustained release…
intestinal medium and the data was further studies using release kinetic models which revealed Higuchi matrix as a best fitted model. Finally, SLN prepared using Precirol ATO5 as solid lipid
lecithin showed highest % drug release (71.39%) with high transdermal flux (69.27). Release kinetics of all formulations showed first order kinetics and followed Higuchi mechanism. Present investigation revealed that…
containing 30% ethanol and 3% soya lecithin showed highest percentage drug release (82.66%). Release kinetics of the optimized formulation showed first order kinetics followed by Higuchi mechanism further followed…
formulation F1-F9 and (0.5, 0.75, 1) ratio in F10-F12. Among various kinetic models drug release was found to best fit the case - II transport, Zero order release model
research in our lab established that ACV can be delivered with near zero-order kinetics from a non-biodegradable silicone implant. The resulting device is also capable of suppressing
covalent reaction. These nanoparticles were characterized using PCS, SEM, mass spectroscopy and immunofluorescence. Release kinetics of loaded drugs was elucidated. The ability to selectively deliver payload to cancer…
hours and the release profile was comparable with reference product (Voltral? SR). The release kinetic models were fitted to characterize the dissolution profiles of microcapsules and tabletted microcapsules. The…
drug molecules by confining them inside matrix and then releasing them with a designed kinetics by diffusion. Drug diffusion is strongly affected by drug interaction with the media of drug ... vectors, and accurate…
controlled manner in nanoparticulate form than in the case of direct dosage. Kinetic studies revealed the sustained and controlled release patterns of the anticancer drug. Based on the results obtained
study showed that TBS did not interact with the formulation excipients. The release kinetics showed that the data followed Higuchi model and the mechanism of drug release was diffusion
microspheres of atenolol exhibited non- Fickian diffusion controlled drug release and followed zero order kinetics. The permeation of atenolol largely depended upon the type of polymer, its concentration and also
drug entrapment efficiency was increased after the addition of PEG 4000. The release kinetics of GLZ from two different (2% and 3%) chitosan scaffold formulations investigated showed sustained and controlled
exhibits the additive or synergistic effects of drugs. However, the specific distinct drug release kinetics of the multiply drugs are required to meet the clinical needs, especially in the combined ... erosion, inner…
pattern with an initial burst followed by sustained release up to 12h. The release kinetics showed anomalous diffusion. The potential irritancy of nanoparticles was evaluated using HET-CAM method
shown highest Percent drug release when compared to the F4 & F5 formulations. The release kinetics of F2, F4 and F5 formulations were studied. All the formulations follow zero-order release ... kinetics and follow…